DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹910 Cr | ₹824 Cr | ₹762 Cr | ₹796 Cr | ₹763 Cr |
What is the latest Trade Payables ratio of DIVIS LABORATORIES ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹910 Cr |
| Mar2024 | ₹824 Cr |
| Mar2023 | ₹762 Cr |
| Mar2022 | ₹796 Cr |
| Mar2021 | ₹763 Cr |
How is Trade Payables of DIVIS LABORATORIES Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹910 Cr | 10.44 | |
| Mar2024 | ₹824 Cr | 8.14 | |
| Mar2023 | ₹762 Cr | -4.24 | |
| Mar2022 | ₹796 Cr | 4.26 | |
| Mar2021 | ₹763 Cr | - | |
Compare Trade Payables of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹169,869.6 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,961.6 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.7% |
3.1% |
5.5% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses